Portulaca oleracea L. (Purslane) extracts display antioxidant and hypoglycaemic effects

Purslane (Portulaca oleracea L.) is a member of the family Portulacaceae. Due to its many health benefits, it is listed in a World Health Organization database. The aim of this work is to investigate the purslane extracts for their chemical profile and bioactivity. In this study, two different solvents (MeOH/H2O and EtOH) were applied to fresh and dried leaves. The extracts were analysed using HPLC-DAD. Phenolic acids (caffeic acid, p-coumaric acid and ferulic acid) and flavonoids (apigenin, kaempferol, luteolin, quercetin, isorhamnetin, kaempferol-3-O-glucoside and rutin) were identified in all samples. Quercetin and p-coumaric acid were the most abundant compounds. Total antioxidant activity was measured by using the ABTS and DPPH tests, and the ferric reducing antioxidant power (FRAP) assay. Hypoglycaemic properties were investigated via the inhibition of carbohydrate-hydrolysing enzymes, α-amylase and α-glucosidase. Fresh hydroalcoholic purslane extract exhibited the highest radical scavenging potential in both ABTS and DPPH test (IC50 values of 52.86 and 66.98 μg/mL, respectively), whereas dried hydroalcoholic purslane extract showed the highest α-glucosidase inhibitory potential (IC50 value of 45.05 μg/mL). Collectively these data show the health properties of this widely consumed salad plant

Identification of a New Complement Factor H Mutation in a Patient With Pregnancy-Related Acute Kidney Injury

n/

Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort

ObjectivesThe development of novel antiviral agents active against Hepatitis Delta Virus (HDV) might change the natural history of chronic infection, reducing the risk for end-stage liver disease. People living with HIV (PWH) are at risk for bloodborne pathogens infection, but limited data on epidemiology of HDV infection is available in this setting. The aim of this study was to investigate HDV prevalence and attitude toward HDV testing and treatment in infectious diseases centers.MethodsA cross sectional survey was performed among centers participating in the CISAI (Coordinamento Italiano per lo Studio dell’Allergia in Infezione da HIV) Group. The survey addressed anti-HDV prevalence and HDV-RNA detectability rates in PWH as well as perceived obstacles to treatment.ResultsOverall, responses from ten sites were collected. Among participating centers, 316 PWH with HBV chronic infection are currently followed. Of them, 15.2% had positive anti-HDV antibodies, while 13.9% were not tested yet. Overall, 17% of anti-HDV positive PWH tested at least once for HDV-RNA had active HDV infection, and 71% of them had advanced liver disease. Most infectious diseases centers intend to treat locally HDV infection with upcoming anti-HDV drugs, but some concerns exist regarding treatment schedule.DiscussionHDV testing needs to be implemented in PWH. At present, few patients followed in the CISAI centers seem to be candidate to receive new direct active anti-HDV agents, but repeated HDV-RNA measures could change this proportion

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?

Background In persons living with HIV (PLWH), the burden of non-communicable chronic diseases increased over time, because of aging associated with chronic inflammation, systemic immune activation, and long-term exposure to the combination antiretroviral therapy (ART). Methods To explore the association of chronological age, age at first ART, and exposure to ART with non-communicable chronic diseases, we performed a cross-sectional analysis to evaluate the prevalence of comorbidities in patients enrolled in the SCOLTA Project, stratified by groups of chronological age (50-59 and 60-69 years) and by years of antiretroviral treatment (ART, <= 3 or > 3 years). Results In 1394 subjects (23.8% women), mean age at enrollment was 57.4 (SD 6.5) years, and at first ART 45.3 (SD 10.7). Men were older than women both at enrollment (57.6 vs 56.8, p = 0.06) and at first ART (45.8 vs 43.6, p = 0.0009). ART duration was longer in women (13.1 vs 11.7 years, p = 0.01). The age- and sex-adjusted rate ratios (aRRs, and 95% confidence interval, CI) showed that longer ART exposure was associated with dyslipidemia (aRR 1.35, 95% CI 1.20-1.52), hypertension (aRR 1.52, 95% CI 1.22-1.89), liver disease (aRR 1.78, 95% CI 1.32-2.41), osteopenia/osteoporosis (aRR 2.88, 95% CI 1.65-5.03) and multimorbidity (aRR 1.36, 95% CI 1.21-1.54). These findings were confirmed in strata of age, adjusting for sex. Conclusions Our data suggest that longer ART exposure was associated with increased risk of dyslipidemia, hypertension, and osteopenia/osteoporosis, hence the presence of multimorbidity, possibly due to the exposition to more toxic antiretrovirals. We observed different comorbidities, according to ART exposure and age

Colorectal cancer after bariatric surgery (Cric-Abs 2020): Sicob (Italian society of obesity surgery) endorsed national survey

Background The published colorectal cancer (CRC) outcomes after bariatric surgery (BS) are conflicting, with some anecdotal studies reporting increased risks. The present nationwide survey CRIC-ABS 2020 (Colo-Rectal Cancer Incidence-After Bariatric Surgery-2020), endorsed by the Italian Society of Obesity Surgery (SICOB), aims to report its incidence in Italy after BS, comparing the two commonest laparoscopic procedures-Sleeve Gastrectomy (SG) and Roux-en-Y gastric bypass (GBP). Methods Two online questionnaires-first having 11 questions on SG/GBP frequency with a follow-up of 5-10 years, and the second containing 15 questions on CRC incidence and management, were administered to 53 referral bariatric, high volume centers. A standardized incidence ratio (SIR-a ratio of the observed number of cases to the expected number) with 95% confidence intervals (CI) was calculated along with CRC incidence risk computation for baseline characteristics. Results Data for 20,571 patients from 34 (63%) centers between 2010 and 2015 were collected, of which 14,431 had SG (70%) and 6140 GBP (30%). 22 patients (0.10%, mean age = 53 +/- 12 years, 13 males), SG: 12 and GBP: 10, developed CRC after 4.3 +/- 2.3 years. Overall incidence was higher among males for both groups (SG: 0.15% vs 0.05%; GBP: 0.35% vs 0.09%) and the GBP cohort having slightly older patients. The right colon was most affected (n = 13) and SIR categorized/sex had fewer values < 1, except for GBP males (SIR = 1.07). Conclusion Low CRC incidence after BS at 10 years (0.10%), and no difference between procedures was seen, suggesting that BS does not trigger the neoplasm development

Forage Potential of Cereal/Legume Intercrops: Agronomic Performances, Yield, Quality Forage and LER in Two Harvesting Times in a Mediterranean Environment

The crop yield and quality of seven annual forages (four grasses and three legumes) in sole crop and in mixtures (ratio 50:50) for oat (Avena sativa L.), Italian ryegrass (Lolium multiflorum Lam.), triticale (x Triticosecale Wittmack), barley (Hordeum vulgare L.), pea (Pisum sativum L.), berseem (Trifolium alexandrinum L.) and common vetch (Vicia sativa L.) were evaluated in a two-year field experiment adopting two harvesting times, green fodder and silage. The main bio-agronomic traits, dry matter forage yield (DMY) and quantity of crude protein (CP) were determined in both sole crop and intercrop. The land equivalent ratio (LER) was used for evaluating biological efficiency and competitive ability of the intercrops. Our results showed that the total calculated LER for fodder and protein yields was always greater than one and corresponded to crop yield advantages of 16.0% and 11.5%, respectively. Our data also highlighted the low competitive ability of the ryegrass in intercrop, which achieved the lowest yield among all the mixtures. Conversely, the same grass showed the best green fodder quality, due to the high incidence of the legume, equal (on average) to 46%. Triticale and barley, harvested for silage (hard dough stage), provided the best quantitative and qualitative results both in sole crop and intercropped with common vetch and pea, determined mainly by the cereal grain

Forage Potential of Cereal/Legume Intercrops: Agronomic Performances, Yield, Quality Forage and LER in Two Harvesting Times in a Mediterranean Environment

The crop yield and quality of seven annual forages (four grasses and three legumes) in sole crop and in mixtures (ratio 50:50) for oat (Avena sativa L.), Italian ryegrass (Lolium multiflorum Lam.), triticale (x Triticosecale Wittmack), barley (Hordeum vulgare L.), pea (Pisum sativum L.), berseem (Trifolium alexandrinum L.) and common vetch (Vicia sativa L.) were evaluated in a two-year field experiment adopting two harvesting times, green fodder and silage. The main bio-agronomic traits, dry matter forage yield (DMY) and quantity of crude protein (CP) were determined in both sole crop and intercrop. The land equivalent ratio (LER) was used for evaluating biological efficiency and competitive ability of the intercrops. Our results showed that the total calculated LER for fodder and protein yields was always greater than one and corresponded to crop yield advantages of 16.0% and 11.5%, respectively. Our data also highlighted the low competitive ability of the ryegrass in intercrop, which achieved the lowest yield among all the mixtures. Conversely, the same grass showed the best green fodder quality, due to the high incidence of the legume, equal (on average) to 46%. Triticale and barley, harvested for silage (hard dough stage), provided the best quantitative and qualitative results both in sole crop and intercropped with common vetch and pea, determined mainly by the cereal grain

Cereal-pea intercrops to improve sustainability in bioethanol production

International audienceThe environmental performance of second-generation biofuels from lignocellulosic biomass, such as crop residues, is foreseen to be superior to that of first-generation biofuels such as maize bioethanol. Moreover, using a legume as an intercrop can reduce costly N fertilizers inputs and can increase the N content of the straw mixture. Therefore, we studied cereal-legume intercrops as a source of food grain and straw bioethanol. We grew field pea and four cultivars of durum wheat, triticale, oat, and barley. Crops were grown during 2 years as a sole crop, in additive intercrop with 100 % of the sole crop density for the cereal and 50 % of sole crop density for the legume, and in replacement intercrop with 50 % of the sole crop density for each crop. Tall cereal cultivars were preferred over shorter cereals for an extra production of straw. Results show that growth resources were used up to 23–26 % more efficiently in intercrop than in sole crop for grain and straw production. Tall cereal cultivars suppressed legume yields in intercrops, thus reducing potential intercrop advantages. Pea in intercrop increased straw mixture N by 54 % the first year and by 91 % the second year, versus cereal alone

Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study

The aim of the present study was to evaluate CD4/CD8 dynamics in patients on dolutegravir (DTG)-based two-drug regimens (2DRs) and compare them with DTG-containing triple-drug regimens (3DRs). A prospective observational study was performed in the context of the SCOLTA cohort. Experienced PWH with HIV-RNA < 50 copies/mL were included if they were on the DTG-2DR, the DTG + tenofovir/emtricitabine (TDF/FTC) regimen, the DTG + tenofovir alafenamide (TAF)/FTC regimen, or the DTG + abacavir/lamivudine (ABC/3TC) regimen; they were followed-up for at least one year. A total of 533 PWH were enrolled, 120 in the DTG + 3TC group, 38 in the DTG + protease inhibitors (PI) group, 67 in the DTG + rilpivirine (RPV) group, 49 in the DTG + TDF/FTC group, 27 in the DTG + TAF/FTC group, and 232 in the DTG + ABC/3TC group. After one year, the CD4/CD8 ratio significantly increased in the PWH treated with DTG + 3TC (+0.08 ± 0.26), DTG + TDF/FTC (+0.1 ± 0.19), and DTG + ABC/3TC (+0.08 ± 0.25). At two years, the CD4/CD8 increase was confirmed for PWH on DTG + TDF/FTC (+0.16 ± 0.28) and DTG + ABC/3TC (+0.1 ± 0.3). In the SCOLTA cohort, PWH on 2DRs experienced a CD4/CD8 increase only in the DTG + 3TC group. Controlled studies with longer follow-up will clarify the long-term immunological and clinical impacts of DTG-2DR